Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Rare germline mutations in African American men diagnosed with early-onset prostate cancer.

Beebe-Dimmer JL, Zuhlke KA, Johnson AM, Liesman D, Cooney KA.

Prostate. 2018 Apr;78(5):321-326. doi: 10.1002/pros.23464. Epub 2018 Jan 21.

2.

Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.

Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ, Zheng SL, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Giles GG, Southey MC, Fitzgerald LM, Rinckleb A, Luedeke M, Maier C, Stanford JL, Ostrander EA, Kaikkonen EM, Sipeky C, Tammela T, Schleutker J, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cancel-Tassin G, Cussenot O, Mandal D, Laurie C, Laurie C; PRACTICAL consortium; International Consortium for Prostate Cancer Genetics, Thibodeau SN, Eeles RA, Kote-Jarai Z, Cannon-Albright L.

Hum Genet. 2016 Aug;135(8):923-38. doi: 10.1007/s00439-016-1690-6. Epub 2016 Jun 4.

3.

Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer.

Lange EM, Ribado JV, Zuhlke KA, Johnson AM, Keele GR, Li J, Wang Y, Duan Q, Li G, Gao Z, Li Y, Xu J, Zheng SL, Cooney KA.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):766-72. doi: 10.1158/1055-9965.EPI-14-0995. Epub 2015 Dec 15.

4.

Mutational landscape of candidate genes in familial prostate cancer.

Johnson AM, Zuhlke KA, Plotts C, McDonnell SK, Middha S, Riska SM, Schaid DJ, Thibodeau SN, Douglas JA, Cooney KA.

Prostate. 2014 Oct;74(14):1371-8. doi: 10.1002/pros.22849. Epub 2014 Aug 11.

5.

Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.

Zuhlke KA, Johnson AM, Tomlins SA, Palanisamy N, Carpten JD, Lange EM, Isaacs WB, Cooney KA.

Prostate. 2014 Jun;74(9):983-90. doi: 10.1002/pros.22818. Epub 2014 May 6.

6.

Genome-wide association scan for variants associated with early-onset prostate cancer.

Lange EM, Johnson AM, Wang Y, Zuhlke KA, Lu Y, Ribado JV, Keele GR, Li J, Duan Q, Li G, Gao Z, Li Y, Xu J, Isaacs WB, Zheng S, Cooney KA.

PLoS One. 2014 Apr 16;9(4):e93436. doi: 10.1371/journal.pone.0093436. eCollection 2014.

7.

HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.

Smith SC, Palanisamy N, Zuhlke KA, Johnson AM, Siddiqui J, Chinnaiyan AM, Kunju LP, Cooney KA, Tomlins SA.

Am J Surg Pathol. 2014 May;38(5):615-26. doi: 10.1097/PAS.0000000000000090.

8.

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.

Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Fitzgerald LM, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Wahlfors T, Tammela T, Schleutker J, Wiklund F, Grönberg H, Emanuelsson M, Carpten J, Bailey-Wilson J, Whittemore AS, Oakley-Girvan I, Hsieh CL, Catalona WJ, Zheng SL, Jin G, Lu L, Xu J; International Consortium for Prostate Cancer Genetics, Camp NJ, Cannon-Albright LA.

Hum Genet. 2014 Mar;133(3):347-56. doi: 10.1007/s00439-013-1384-2. Epub 2013 Oct 26.

9.

Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

Beebe-Dimmer JL, Isaacs WB, Zuhlke KA, Yee C, Walsh PC, Isaacs SD, Johnson AM, Ewing CE, Humphreys EB, Chowdhury WH, Montie JE, Cooney KA.

BJU Int. 2014 May;113(5):830-5. doi: 10.1111/bju.12522. Epub 2014 Mar 5.

10.

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS, Cancel-Tassin G, Cussenot O, Wiklund F, Grönberg H, Eeles R, Easton D, Kote-Jarai Z, Whittemore AS, Hsieh CL, Giles GG, Hopper JL, Severi G, Catalona WJ, Mandal D, Ledet E, Foulkes WD, Hamel N, Mahle L, Moller P, Powell I, Bailey-Wilson JE, Carpten JD, Seminara D, Cooney KA, Isaacs WB; International Consortium for Prostate Cancer Genetics.

Hum Genet. 2013 Jan;132(1):5-14. doi: 10.1007/s00439-012-1229-4. Epub 2012 Oct 12.

11.

Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.

Schroeck FR, Zuhlke KA, Siddiqui J, Siddiqui R, Cooney KA, Wei JT.

J Urol. 2013 Mar;189(3):849-53. doi: 10.1016/j.juro.2012.09.117. Epub 2012 Oct 2.

12.

Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.

Zuhlke KA, Johnson AM, Okoth LA, Stoffel EM, Robbins CM, Tembe WA, Salinas CA, Zheng SL, Xu J, Carpten JD, Lange EM, Isaacs WB, Cooney KA.

Fam Cancer. 2012 Dec;11(4):595-600. doi: 10.1007/s10689-012-9555-1.

13.

Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.

Beebe-Dimmer JL, Iyer PT, Nriagu JO, Keele GR, Mehta S, Meliker JR, Lange EM, Schwartz AG, Zuhlke KA, Schottenfeld D, Cooney KA.

Environ Health. 2012 Jun 29;11:43. doi: 10.1186/1476-069X-11-43.

14.

Germline mutations in HOXB13 and prostate-cancer risk.

Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, Wiley KE, Isaacs SD, Johng D, Wang Y, Bizon C, Yan G, Gielzak M, Partin AW, Shanmugam V, Izatt T, Sinari S, Craig DW, Zheng SL, Walsh PC, Montie JE, Xu J, Carpten JD, Isaacs WB, Cooney KA.

N Engl J Med. 2012 Jan 12;366(2):141-9. doi: 10.1056/NEJMoa1110000.

15.

Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).

Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Grönberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J; International Consortium for Prostate Cancer Genetics.

Hum Genet. 2012 Jul;131(7):1095-103. doi: 10.1007/s00439-011-1136-0. Epub 2011 Dec 25.

16.

Early onset prostate cancer has a significant genetic component.

Lange EM, Salinas CA, Zuhlke KA, Ray AM, Wang Y, Lu Y, Ho LA, Luo J, Cooney KA.

Prostate. 2012 Feb 1;72(2):147-56. doi: 10.1002/pros.21414. Epub 2011 May 2.

17.

Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.

Wang Y, Ray AM, Johnson EK, Zuhlke KA, Cooney KA, Lange EM.

Prostate. 2011 Feb 15;71(3):225-31. doi: 10.1002/pros.21234. Epub 2010 Aug 17.

18.

Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.

Beebe-Dimmer JL, Zuhlke KA, Ray AM, Lange EM, Cooney KA.

Prostate Cancer Prostatic Dis. 2010 Dec;13(4):362-8. doi: 10.1038/pcan.2010.27. Epub 2010 Aug 10.

19.

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.

Ray AM, Zuhlke KA, Johnson GR, Levin AM, Douglas JA, Lange EM, Cooney KA.

Br J Cancer. 2009 Dec 15;101(12):2043-7. doi: 10.1038/sj.bjc.6605433. Epub 2009 Nov 24.

20.

Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.

Ray AM, Zuhlke KA, Levin AM, Douglas JA, Cooney KA, Petros JA.

Prostate. 2009 Jun 15;69(9):956-60. doi: 10.1002/pros.20943.

21.

Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.

Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, Walters S, Cooney KA.

Prostate. 2009 Mar 1;69(4):385-91. doi: 10.1002/pros.20891.

22.

Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.

Levin AM, Machiela MJ, Zuhlke KA, Ray AM, Cooney KA, Douglas JA.

Cancer Res. 2008 Aug 15;68(16):6492-5. doi: 10.1158/0008-5472.CAN-08-0348.

23.

Chromosome 8q24 markers: risk of early-onset and familial prostate cancer.

Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, Johnson GR, Cooney KA, Douglas JA.

Int J Cancer. 2008 Jun 15;122(12):2876-9. doi: 10.1002/ijc.23471.

24.

Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.

Levin AM, Zuhlke KA, Ray AM, Cooney KA, Douglas JA.

Prostate. 2007 Oct 1;67(14):1507-13.

25.

Common variation in the BRCA1 gene and prostate cancer risk.

Douglas JA, Levin AM, Zuhlke KA, Ray AM, Johnson GR, Lange EM, Wood DP, Cooney KA.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1510-6. Epub 2007 Jun 21.

26.

Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans.

Levin AM, Ray AM, Zuhlke KA, Douglas JA, Cooney KA.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1294-7.

27.

Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.

Douglas JA, Zuhlke KA, Beebe-Dimmer J, Levin AM, Gruber SB, Wood DP, Cooney KA.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):2035-9.

28.

INSPstI polymorphism and prostate cancer in African-American men.

Claeys GB, Sarma AV, Dunn RL, Zuhlke KA, Beebe-Dimmer J, Montie JE, Wojno KJ, Schottenfeld D, Cooney KA.

Prostate. 2005 Sep 15;65(1):83-7.

29.

Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.

Zuhlke KA, Madeoy JJ, Beebe-Dimmer J, White KA, Griffin A, Lange EM, Gruber SB, Ostrander EA, Cooney KA.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):5975-80.

30.

Risk perception and concern among brothers of men with prostate carcinoma.

Beebe-Dimmer JL, Wood DP Jr, Gruber SB, Chilson DM, Zuhlke KA, Claeys GB, Cooney KA.

Cancer. 2004 Apr 1;100(7):1537-44.

31.

Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.

Beebe-Dimmer JL, Wood DP Jr, Gruber SB, Douglas JA, Bonner JD, Mohai C, Zuhlke KA, Shepherd C, Cooney KA.

Urology. 2004 Feb;63(2):282-7.

PMID:
14972472
32.

RNASEL mutations in hereditary prostate cancer.

Chen H, Griffin AR, Wu YQ, Tomsho LP, Zuhlke KA, Lange EM, Gruber SB, Cooney KA.

J Med Genet. 2003 Mar;40(3):e21. No abstract available.

Supplemental Content

Loading ...
Support Center